Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Larimar Therapeutics, Inc. (LRMR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Larimar Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1374690.
Total stock buying since 2015: $112,610,296.
Total stock sales since 2015: $15,823,840.
Total stock option exercises since 2015: $479,325.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 9,375,000 | $30,000,000 | 0 | $0 | 0 | $0 |
| 2024 | 4,349,825 | $38,021,989 | 0 | $0 | 0 | $0 |
| 2023 | 17,750 | $66,072 | 0 | $0 | 0 | $0 |
| 2022 | 11,492,060 | $36,199,987 | 0 | $0 | 0 | $0 |
| 2021 | 685,710 | $5,999,962 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 37,000 | $370,000 | 0 | $0 |
| 2017 | 30,000 | $116,890 | 0 | $0 | 93,211 | $72,052 |
| 2016 | 393,038 | $2,205,396 | 1,341,499 | $4,443,044 | 35,000 | $26,250 |
| 2015 | 0 | $0 | 258,461 | $11,010,796 | 103,500 | $381,023 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 9,375,000 | $30,000,000 | 0 | $0 | 0 | $0 |
| 2024-02 | 4,349,825 | $38,021,989 | 0 | $0 | 0 | $0 |
| 2023-12 | 5,000 | $18,660 | 0 | $0 | 0 | $0 |
| 2023-05 | 12,750 | $47,412 | 0 | $0 | 0 | $0 |
| 2022-09 | 11,492,060 | $36,199,987 | 0 | $0 | 0 | $0 |
| 2021-06 | 685,710 | $5,999,962 | 0 | $0 | 0 | $0 |
| 2018-06 | 0 | $0 | 32,000 | $320,000 | 0 | $0 |
| 2018-03 | 0 | $0 | 5,000 | $50,000 | 0 | $0 |
| 2017-10 | 10,000 | $38,990 | 0 | $0 | 0 | $0 |
| 2017-07 | 10,000 | $33,900 | 0 | $0 | 0 | $0 |
| 2017-05 | 10,000 | $44,000 | 0 | $0 | 93,211 | $72,052 |
| 2016-12 | 10,000 | $32,290 | 0 | $0 | 0 | $0 |
| 2016-11 | 10,000 | $35,430 | 0 | $0 | 0 | $0 |
| 2016-08 | 10,000 | $29,990 | 0 | $0 | 0 | $0 |
| 2016-07 | 31,000 | $94,866 | 1,341,499 | $4,443,044 | 25,000 | $18,750 |
| 2016-02 | 332,038 | $2,012,820 | 0 | $0 | 0 | $0 |
| 2016-01 | 0 | $0 | 0 | $0 | 10,000 | $7,500 |
| 2015-09 | 0 | $0 | 253,461 | $10,841,344 | 103,500 | $381,023 |
| 2015-06 | 0 | $0 | 5,000 | $169,452 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-31 | Deerfield Partners, L.p. | Buy | 9,375,000 | 3.20 | 30,000,000 |
| 2024-02-16 | Hamilton Thomas Edward (Director) | Buy | 57,208 | 8.74 | 499,997 |
| 2024-02-16 | Deerfield Partners, L.p. | Buy | 4,290,617 | 8.74 | 37,499,992 |
| 2024-02-14 | Thomas Frank E (Director) | Buy | 2,000 | 11.00 | 22,000 |
| 2023-12-07 | Shankar Gopi (Chief Development Officer) | Buy | 5,000 | 3.73 | 18,660 |
| 2023-05-17 | Ben-maimon Carole (President and CEO) | Buy | 5,000 | 3.71 | 18,525 |
| 2023-05-17 | Truitt Joseph (Director) | Buy | 2,750 | 3.73 | 10,257 |
| 2023-05-17 | Celano Michael (Chief Financial Officer) | Buy | 5,000 | 3.73 | 18,630 |
| 2022-09-16 | Hamilton Thomas Edward (Director) | Buy | 317,460 | 3.15 | 999,999 |
| 2022-09-16 | Deerfield Private Design Fund Iv, L.p. | Buy | 11,111,108 | 3.15 | 34,999,990 |
| 2022-09-16 | Ben-maimon Carole (President and CEO) | Buy | 31,746 | 3.15 | 99,999 |
| 2022-09-16 | Celano Michael (Chief Financial Officer) | Buy | 31,746 | 3.15 | 99,999 |
| 2021-06-30 | Deerfield Private Design Fund Iv, L.p. | Buy | 685,710 | 8.75 | 5,999,962 |
| 2018-06-28 | Hughes Thomas E. (See Remarks) | Sale | 32,000 | 10.00 | 320,000 |
| 2018-03-07 | Hughes Thomas E. (See Remarks) | Sale | 5,000 | 10.00 | 50,000 |
| 2017-10-13 | Heller Frances K (Director) | Buy | 10,000 | 3.90 | 38,990 |
| 2017-07-11 | Kim Dennis D (Chief Medical Officer) | Buy | 10,000 | 3.39 | 33,900 |
| 2017-05-11 | Hughes Thomas E. (President and CEO) | Option Ex | 93,211 | .77 | 72,052 |
| 2017-05-11 | Kim Dennis D (Chief Medical Officer) | Buy | 9,800 | 4.40 | 43,120 |
| 2017-05-10 | Kim Dennis D (Chief Medical Officer) | Buy | 200 | 4.40 | 880 |
| 2016-12-19 | Heller Frances K (Director) | Buy | 10,000 | 3.23 | 32,290 |
| 2016-11-15 | Heller Frances K (Director) | Buy | 10,000 | 3.54 | 35,430 |
| 2016-08-29 | Hughes Thomas E. (President and CEO) | Buy | 10,000 | 3.00 | 29,990 |
| 2016-07-26 | Allen Patricia L (Chief Financial Officer) | Buy | 8,200 | 3.15 | 25,830 |
| 2016-07-25 | Allen Patricia L (Chief Financial Officer) | Buy | 7,800 | 3.08 | 24,031 |
| 2016-07-22 | Hughes Thomas E. (President and CEO) | Buy | 5,000 | 3.02 | 15,105 |
| 2016-07-22 | Hughes Thomas E. (President and CEO) | Option Ex | 25,000 | .75 | 18,750 |
| 2016-07-22 | Heller Frances K (Director) | Buy | 10,000 | 2.99 | 29,900 |
| 2016-07-20 | Deerfield Special Situations Fund, L.p. | Sale | 1,341,499 | 3.31 | 4,443,044 |
| 2016-02-12 | Deerfield Special Situations Fund, L.p. | Buy | 64,545 | 6.25 | 403,212 |
| 2016-02-11 | Deerfield International Master Fund, L.p. | Buy | 2,344 | 6.19 | 14,504 |
| 2016-02-10 | Deerfield International Master Fund, L.p. | Buy | 151,226 | 6.23 | 942,440 |
| 2016-02-09 | Deerfield International Master Fund, L.p. | Buy | 113,923 | 5.73 | 652,664 |
| 2016-01-08 | Hughes Thomas E. (Chief Executive Officer) | Option Ex | 10,000 | .75 | 7,500 |
| 2015-09-24 | Starr Kevin P (Director) | Sale | 136,579 | 43.91 | 5,997,866 |
| 2015-09-23 | Hughes Thomas E. (Chief Executive Officer) | Option Ex | 10,500 | .75 | 7,875 |
| 2015-09-18 | Goldberg Avi Y. (Director) | Sale | 5,000 | 45.00 | 225,000 |
| 2015-09-18 | Hughes Thomas E. (Chief Executive Officer) | Sale | 23,126 | 45.00 | 1,040,670 |
| 2015-09-18 | Hughes Thomas E. (Chief Executive Officer) | Option Ex | 23,126 | 2.45 | 56,658 |
| 2015-09-17 | Hughes Thomas E. (Chief Executive Officer) | Sale | 22,500 | 40.00 | 900,000 |
| 2015-09-17 | Hughes Thomas E. (Chief Executive Officer) | Option Ex | 4,874 | 2.45 | 11,941 |
| 2015-09-17 | Secor Alicia (Chief Commercial Officer) | Sale | 26,256 | 41.05 | 1,077,808 |
| 2015-09-17 | Secor Alicia (Chief Commercial Officer) | Option Ex | 25,000 | 9.67 | 241,750 |
| 2015-09-17 | Kim Dennis D (Chief Medical Officer) | Sale | 9,142 | 40.00 | 365,680 |
| 2015-09-17 | Kim Dennis D (Chief Medical Officer) | Option Ex | 9,142 | 1.57 | 14,352 |
| 2015-09-15 | Kim Dennis D (Chief Medical Officer) | Sale | 30,265 | 40.00 | 1,210,600 |
| 2015-09-15 | Kim Dennis D (Chief Medical Officer) | Option Ex | 30,265 | 1.57 | 47,516 |
| 2015-09-14 | Kim Dennis D (Chief Medical Officer) | Sale | 593 | 40.00 | 23,720 |
| 2015-09-14 | Kim Dennis D (Chief Medical Officer) | Option Ex | 593 | 1.57 | 931 |
| 2015-06-10 | Goldberg Avi Y. (Director) | Sale | 3,000 | 35.00 | 105,000 |
| 2015-06-01 | Goldberg Avi Y. (Director) | Sale | 2,000 | 32.23 | 64,452 |
Insider trading activities including stock purchases, stock sales, and option exercises of LRMR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Larimar Therapeutics, Inc. (symbol LRMR, CIK number 1374690) see the Securities and Exchange Commission (SEC) website.